Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hiroki Hayano"'
Autor:
Riho Kanai, Shinichiro Kuroshima, Michimasa Kamo, Muneteru Sasaki, Yusuke Uto, Nao Inaba, Yusuke Uchida, Hiroki Hayano, Saki Tamaki, Maaya Inoue, Takashi Sawase
Publikováno v:
International Journal of Implant Dentistry, Vol 6, Iss 1, Pp 1-12 (2020)
Abstract Background To explore the effects of topographical modification of titanium substrates at submicron level by oxalic acid treatment on bone quality and quantity around dental implants in rabbit tibiae. Methods A total of 60 blasted CP-grade I
Externí odkaz:
https://doaj.org/article/0edad28458b242baa68e1e43cc9aa62f
Autor:
Haruka Kaneko, Shinichiro Kuroshima, Ryohei Kozutsumi, Farah A. Al-Omari, Hiroki Hayano, Kazunori Nakajima, Takashi Sawase
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 5
Pages: 1914
Volume 12
Issue 5
Pages: 1914
The pathophysiology, pathogenesis, histopathology, and immunopathology of medicationrelated osteonecrosis of the jaw (MRONJ) Stage 0 remain unclear, although 50% of MRONJ Stage 0 cases could progress to higher stages. The aim of this study was to inv
Autor:
Kazunori Nakajima, Maaya Inoue, Muneteru Sasaki, Ryohei Kozutsumi, Hiroki Hayano, Shinichiro Kuroshima, Takashi Sawase
Publikováno v:
Journal of Prosthodontic Research. 65:546-553
Purpose The aim of the present study was to investigate the effects of chemotherapeutic/bisphosphonate combination therapy with tooth extraction on gene expression patterns of fresh extraction wounds during initial stages prior to their diagnosis as
Autor:
Saki Tamaki, Takashi Sawase, Kazunori Nakajima, Akira Ishisaki, Shinichiro Kuroshima, Hiroe Kakehashi, Hiroki Hayano
Publikováno v:
Bone. 141
Denosumab-related osteonecrosis of the jaw (DRONJ), which mainly occurs in cancer patients receiving anti-receptor activator NF-kappaB ligand (RANKL) antibody, reduces oral health-related quality of life. However, the exact mechanisms of and definiti
Autor:
Hiroki Hayano, Takashi Sawase, Muneteru Sasaki, Shinichiro Kuroshima, Kazunori Nakajima, Riho Kanai, Yuri Akita
Publikováno v:
Journal of Bone and Mineral Metabolism. 36:547-559
Osteonecrosis of the jaw (ONJ), which is a rare but severe adverse effect, mainly occurs in oncology patients receiving chemotherapeutic agents and bisphosphonates. However, the combined impact of chemotherapy and bisphosphonates on wound healing aft
Autor:
Hiroki Hayano, Muneteru Sasaki, Saki Tamaki, Takashi Sawase, Kazunori Nakajima, Shinichiro Kuroshima
Publikováno v:
Journal of Bone and Mineral Research. 33:154-166
The precise pathoetiology and effective treatment strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ) remain unknown. Transplantation of noncultured stromal vascular fraction (SVF) cells has been shown to be a useful method for reg
Autor:
Hiroki Hayano, Akira Ishisaki, Maaya Inoue, Takashi Sawase, Muneteru Sasaki, Shinichiro Kuroshima, Saki Tamaki
Publikováno v:
Bone. 135
There is limited information about denosumab-related osteonecrosis of the jaw (DRONJ), unlike bisphosphonate-related ONJ (BRONJ). The mode of action is clearly different between denosumab and bisphosphonates. DRONJ occurs mainly following tooth extra
Autor:
Shinichiro Kuroshima, Kazunori Nakajima, Muneteru Sasaki, Hiroki Hayano, Maaya Inoue, Ryohei Kozutsumi, Takashi Sawase
Publikováno v:
Journal of Prosthodontic Research; 2021, Vol. 65 Issue 4, p546-553, 8p
Autor:
Muneteru Sasaki, Takashi Sawase, Shinichiro Kuroshima, Kazunori Nakajima, Saki Tamaki, Hiroki Hayano
Publikováno v:
Bone. 112
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) worsens oral health-related quality of life. Most BRONJ occurs in multiple myeloma or metastatic breast cancer patients treated with bisphosphonate/chemotherapeutic combination therapies. Cyclop